BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25701553)

  • 1. Is salivary epidermal growth factor a biomarker for oral leukoplakia? A preliminary study.
    Jaeger F; Assunção AC; Caldeira PC; Queiroz-Junior CM; Bernardes VF; de Aguiar MC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):451-8. PubMed ID: 25701553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF in saliva and tumor samples of oral squamous cell carcinoma.
    Bernardes VF; Gleber-Netto FO; Sousa SF; Silva TA; Abreu MH; Aguiar MC
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):528-33. PubMed ID: 21436680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis.
    Adişen E; Aral A; Aybay C; Gürer MA
    Dermatology; 2008; 217(3):235-40. PubMed ID: 18663306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary epidermal growth factor concentration in adults with reflux laryngitis.
    Eckley CA; Michelsohn N; Rizzo LV; Tadokoro CE; Costa HO
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):401-6. PubMed ID: 15467608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome.
    Koski H; Konttinen YT; Hietanen J; Tervo T; Malmström M
    J Rheumatol; 1997 Oct; 24(10):1930-5. PubMed ID: 9330934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinicopathological study.
    Shetty SR; Chadha R; Babu S; Kumari S; Bhat S; Achalli S
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S123-5. PubMed ID: 22322730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
    Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
    Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary epidermal growth factor in oral cavity cancer.
    Balicki R; Grabowska SZ; Citko A
    Oral Oncol; 2005 Jan; 41(1):48-55. PubMed ID: 15598585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of epidermal growth factor in saliva.
    Ino M; Ushiro K; Ino C; Yamashita T; Kumazawa T
    Acta Otolaryngol Suppl; 1993; 500():126-30. PubMed ID: 8452009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary concentration of epidermal growth factor in adults with reflux laryngitis before and after treatment.
    Eckley CA; Sardinha LR; Rizzo LV
    Ann Otol Rhinol Laryngol; 2013 Jul; 122(7):440-4. PubMed ID: 23951695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
    Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
    Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
    Liu CJ; Lin SC; Yang CC; Cheng HW; Chang KW
    Head Neck; 2012 Feb; 34(2):219-24. PubMed ID: 22083872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated salivary EGF levels stimulated by periodontal surgery.
    Oxford GE; Nguyen KH; Alford CE; Tanaka Y; Humphreys-Beher MG
    J Periodontol; 1998 Apr; 69(4):479-84. PubMed ID: 9609379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
    Hoffmann RR; Yurgel LS; Campos MM
    Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated salivary endothelin levels in oral cancer patients--a pilot study.
    Pickering V; Jordan RC; Schmidt BL
    Oral Oncol; 2007 Jan; 43(1):37-41. PubMed ID: 16757207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and quantitative changes in salivary EGF, amylase and haptocorrin following radiotherapy for oral cancer.
    Christensen ME; Hansen HS; Poulsen SS; Bretlau P; Nexo E
    Acta Otolaryngol; 1996 Jan; 116(1):137-43. PubMed ID: 8820365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor in neonatal saliva.
    Gupta A; Lakhoo K; Pritchard N; Herbert M
    Eur J Pediatr Surg; 2008 Aug; 18(4):245-8. PubMed ID: 18629765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased rate of salivary epidermal growth factor secretion in patients with juvenile periodontitis.
    Hormia M; Thesleff I; Perheentupa J; Pesonen K; Saxén L
    Scand J Dent Res; 1993 Jun; 101(3):138-44. PubMed ID: 8322007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and secretion of epidermal growth factor in the parotid gland and its intragastric kinetics in sheep.
    Onaga T; Shimizu Y; Hayashi H; Tsuji M; Endoh D; Okada H
    Life Sci; 2006 Sep; 79(17):1616-29. PubMed ID: 16777144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary metabolomics for oral leukoplakia with and without dysplasia.
    Kitabatake K; Ishikawa S; Sugimoto M; Enomoto A; Kaneko M; Ota S; Edamatsu K; Yusa K; Hemmi T; Okuyama N; Iino M
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101618. PubMed ID: 37659754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.